About Maiva Pharma
Maiva Pharma is a Healthcare company based in Hosur (India) founded in 1996. Formulation development, analytical validation, and injectable supplies are provided. Maiva Pharma has raised $133.38 million across 10 funding rounds from investors including Morgan Stanley, PharmaScience and Mahaganapati Advisors. The company has 751 employees. Maiva Pharma was last valued at $13.6 million in March 2016. Its chief executive, as recorded, is Bhaskar Krishna Arumugam. Its Indian entity Maiva Pharma Private Limited reported revenue of ₹393 Cr. Maiva Pharma offers products and services including Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed competitors have raised funding.
Company details
Maiva Pharma was founded in 1996 and is based in Hosur, India. Operations focus on the pharmaceutical sector, where formulation development and analytical method validation services are offered. Injectable supply services are also managed to support manufacturing needs. The company serves clients through these core activities in a specialized environment.
- Headquarters Hosur, India
- Employees 751
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website maivapharma.com
- Social LinkedIn
- Legal Name Maiva Pharma Private Limited
- Date of Incorporation 05 Feb, 1993
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹393 Cr
FY 2025 · +38% YoY
- Net Profit₹77.08 Cr
FY 2025 · 21% margin
- EBITDA₹127 Cr
FY 2025 · 34% margin
- Total Equity Funding$133.38M (USD)
in 10 rounds
- Latest Funding Round$119.8M (USD), Unspecified
Apr 2024
- InvestorsMorgan Stanley
& 8 more
- Employee Count751
Associated legal entities of Maiva Pharma
Maiva Pharma is associated with 3 registered companies on The Company Check; the primary company is Maiva Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Maiva Pharma Private Limited CIN U24231TZ1993PTC041204 | Active | 05 Feb 1993 | Bangalore, Karnataka | ₹393 Cr | 751 | 6 | View details |
| Maiva Pharma Private Limited CIN U24231KA1993PTC013976 | 05 Feb 1993 | Bangalore, Karnataka, India | View details | ||||
| Mahaganapati Business Advisors Llp CIN AAF-2007 | Active | 23 Nov 2015 | Bangalore, Karnataka | 2 | View details |
Products & Services of Maiva Pharma
Maiva Pharma offers a comprehensive portfolio of products and services, including Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study.
Manufactures sterile liquid pharmaceuticals for medical use.
Produces freeze-dried pharmaceutical products for stability.
Conducts studies to assess material safety in pharmaceuticals.
Evaluates container integrity for pharmaceutical applications.
Analyzes impurities to meet pharmaceutical standards.
Funding Insights of Maiva Pharma
Maiva Pharma has successfully raised a total of $133.38M across 10 strategic funding rounds. The most recent funding activity was a Unspecified round of $119.8 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $133.38M
- Total Rounds 10
- Last Round Unspecified — $119.8M
- First Round $1.67M
(Oct 2009)
- Investors Count 9
All 10 funding rounds of Maiva Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $119.8M | Unspecified | – | InvAscent, Nhpea V Spear | |
| Feb 2024 | $1.97M | Seed | – | – | – |
| Jun 2020 | $2.21M | Series A | – | – | – |
| Jul 2019 | $4.36M | Series A | – | – | – |
| Mar 2016 | $941,315 | Unspecified | $13.6M | – | |
| Feb 2016 | $174,848 | Unspecified | $9.28M | Mahaganapati Advisors | – |
| Sep 2014 | $2.07M | Unspecified | $••••• | PharmaScience | – |
| Apr 2011 | $177,886 | Unspecified | $••••• | Anna Thomas Chacko | – |
| Jul 2010 | Unspecified | – | – | ||
| Oct 2009 | $1.67M | Unspecified | $••••• | Exodus Technologies |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2016 | $13.6M | •••••••• |
| Feb 2016 | $9.28M | •••••••• |
| Sep 2014 | $••••• | •••••••• |
| Apr 2011 | $••••• | •••••••• |
| Oct 2009 | $••••• | •••••••• |
Full valuation and stage history of Maiva Pharma
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $13.6M (Mar 2016). 9 investors in total: 7 institutional and 2 angel.
Investors in Maiva Pharma
Maiva Pharma has secured backing from 9 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Morgan Stanley, PharmaScience and Mahaganapati Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on life sciences investments in India. | 2005 | invascent.com | ||
Generic, branded, and over-the-counter pharmaceuticals are manufactured for global markets. | 1983 | pharmascience.com | Montreal, Canada | |
Business advisory consulting services are provided to various clients. | ||||
Provides online solutions for solar monitoring and peer-to-peer trading to optimize energy management. | 1996 | exodus-technologies.com | Leeds, United Kingdom | |
Wealth management, investment advisory, and financial services are provided. | 1935 | morganstanley.com | New York, United States | |
AT Anna Thomas Chacko | unknown_95248521277d42d7b | |||
TT T Thomas | unknown_5913daa5a03b4d159 | |||
NanoVista is recognized for producing indestructible and flexible eyewear for children. | nano-vista.com | Spain |
Investor details for Maiva Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Maiva Pharma Private Limited (Maiva Pharma)
Maiva Pharma Private Limited is the primary company behind Maiva Pharma. The boards of the 2 registered companies of Maiva Pharma currently have 6 directors; the longest-serving is Arumugam Bhaskar Krishna, appointed in 2015. 25 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arumugam Bhaskar Krishna DIN 03581041 | Designated Partner | 23 Nov 2015 | 10 yrs 11 mo | Mahaganapati Business Advisors Llp, Maiva Pharma Private Limited |
| Anand Prakash Narayan DIN 06681148 | Designated Partner | 23 Nov 2015 | 10 yrs 11 mo | Mahaganapati Business Advisors Llp |
| Janardhan DIN 09293521 | Whole-time director | 25 Aug 2021 | 5 yrs 2 mo | Maiva Pharma Private Limited |
| Nirav Vinod Mehta DIN 07504945 | Director | 30 Apr 2024 | 2 yrs 6 mo | Maiva Pharma Private Limited |
| Vaibhav Bagri DIN 10631486 | Director | 31 Jul 2024 | 2 yrs 3 mo | Maiva Pharma Private Limited |
| Buggana Hariharnath DIN 00695002 | Director | 13 Sep 2024 | 2 yrs 2 mo | Maiva Pharma Private Limited |
People of Maiva Pharma
7 people are tracked at Maiva Pharma (2 in leadership, 5 in team); the tracked headcount is 751.
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership | |
Dr. Bhaskar Krishna | CEO | Leadership |
Ashok K | Lead - Strategic Sourcing And Procurement (direct & Indirect) | Team |
Madhusudhan R | Assistant Manager | Team |
Pon Ayyappan S | Senior Manager | Team |
Ajithkumar P | Senior Executive | Team |
Jackson Silva | Senior Manager - Business Development And Strategy | Team |
Complete people profiles for Maiva Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Maiva Pharma
Figures of Maiva Pharma Private Limited, the primary company behind Maiva Pharma, for FY 2025. Revenue was ₹393 Cr (+38% year on year). Net profit was ₹77.08 Cr (21% margin). EBITDA was ₹127 Cr (34% margin). Revenue has grown at a compounded annual rate of +34% over three years and +49% over five years.
- ₹393 CrRevenue · FY 2025 · +38% YoY
- ₹77.08 CrNet profit · 21% margin
- ₹127 CrEBITDA · 34% margin
- ₹24.66 CrPaid-up capital
- 751Employees (provident fund records)
- +34%Revenue CAGR, 3 years
- +49%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Maiva Pharma Private Limited are on its company page.
Detailed financial statements for Maiva Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Maiva Pharma
4 dated milestones of Maiva Pharma across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Maiva Pharma is founded.
- Funding First funding round of $1.7M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Unspecified, of $119.8M.
Competitors of Maiva Pharma
Maiva Pharma has 3 listed competitors in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed competitors of Maiva Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Maiva Pharma
The website of Maiva Pharma (maivapharma.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 65.4% vs previous month
Websites whose visitors overlap most with Maiva Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
maiva.co | maiva.co | 100% | #1,392,508 | – | |
| eucareindia.com | 89% | 1.3K | #13,853,573 | View details | |
| malladi.com | 72% | 1.6K | #9,503,567 | View details | |
| avstechipl.in | 71% | #9,747,647 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Maiva Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Maiva Pharma
Complete news archive for Maiva Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maiva Pharma
Maiva Pharma was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Maiva Pharma is headquartered in Hosur, India. It is registered at Hosur, Tamil Nadu, India.
Bhaskar Krishna Arumugam is the CEO of Maiva Pharma, as recorded in our data.
Maiva Pharma is a funded company, having raised a total of $133.38M across 10 funding rounds to date. The company's 1st funding round was a Unspecified of $1.67M, raised on Oct 2009.
Maiva Pharma has 751 employees.
The primary company behind Maiva Pharma, Maiva Pharma Private Limited, reported revenue of ₹393 Cr for FY 2025, up 38% year on year.
Maiva Pharma was founded in 1996 and is based in Hosur, India. Operations focus on the pharmaceutical sector, where formulation development and analytical method validation services are offered. Injectable supply services are also managed to support manufacturing needs. The company serves clients through these core activities in a specialized environment.
Maiva Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Maiva Pharma offers Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study.
Maiva Pharma has 9 investors. Key investors include Morgan Stanley, PharmaScience, Mahaganapati Advisors, Anna Thomas Chacko, and T Thomas.
The valuation of Maiva Pharma is $13.6M as of Mar 2016.
Maiva Pharma is associated with 2 legal entities: Maiva Pharma Private Limited, Mahaganapati Business Advisors Llp.